News Drug firms use legal loopholes to safeguard brand names BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7257.320/b (Published 05 August 2000) Cite this as: BMJ 2000;321:320 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Trump chooses Obamacare opponent to lead Health and Human Services BMJ November 30, 2016, 355 i6469; DOI: https://doi.org/10.1136/bmj.i6469 Drug firms need to tackle affordability BMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096 World Medical Association’s tainted president, Ketan Desai BMJ November 10, 2016, 355 i5867; DOI: https://doi.org/10.1136/bmj.i5867 Cancer drugs, survival, and ethics BMJ November 09, 2016, 355 i5792; DOI: https://doi.org/10.1136/bmj.i5792 WHO refers $29m Oxford research project to GMC for misconduct BMJ November 07, 2016, 355 i5971; DOI: https://doi.org/10.1136/bmj.i5971